Lonza Group AG
LONN
Peringkat dalam Saham
#447
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Harga Saham
$766.95
Kapitalisasi Pasar
$53.57B
Perubahan (1 hari)
1.35%
Perubahan (1 tahun)
9.01%
Negara
CH
Perdagangan Lonza Group AG (LONN)
Kategori
Healthcare
Pendapatan untuk Lonza Group AG (LONN)
Pendapatan pada Oct 2026 TTM: 0
Menurut laporan keuangan terbaru dari Lonza Group AG, pendapatan saat ini (TTM) adalah 0. Pada tahun 2026, perusahaan menghasilkan pendapatan sebesar 0 sama dengan pendapatan pada tahun 2026 yang sebesar 0. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Lonza Group AG dari 2004 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Mengubah |
|---|---|---|
| 2025 | $8.23B | 35.66% |
| 2024 | $6.07B | -24.04% |
| 2023 | $7.99B | 18.66% |
| 2022 | $6.73B | 13.45% |
| 2021 | $5.93B | 18.22% |
| 2020 | $5.02B | 15.40% |
| 2019 | $4.35B | -22.81% |
| 2018 | $5.63B | 20.73% |
| 2017 | $4.67B | 14.94% |
| 2016 | $4.06B | 6.70% |
| 2015 | $3.80B | 3.83% |
| 2014 | $3.66B | -8.77% |
| 2013 | $4.02B | -6.34% |
| 2012 | $4.29B | 49.65% |
| 2011 | $2.87B | -0.07% |
| 2010 | $2.87B | 10.16% |
| 2009 | $2.60B | -5.33% |
| 2008 | $2.75B | 8.28% |
| 2007 | $2.54B | 35.49% |
| 2006 | $1.87B | 30.23% |
| 2005 | $1.44B | -25.02% |
| 2004 | $1.92B | 0.00% |
Pendapatan untuk perusahaan serupa atau pesaing
| Perusahaan | Pendapatan | Perbedaan Pendapatan | Negara |
|---|---|---|---|
| $12.62B | - |
US
|
|
| $2.23B | - |
US
|
|
| $15.74B | - |
AU
|
|
| $6.02B | - |
NL
|
|
| $10.11B | - |
BE
|
